Dodge & Cox’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $795M | Sell |
|
|||||
|
2025
Q2 | $831M | Buy |
|
|||||
|
2025
Q1 | $1.06B | Buy |
|
|||||
|
2024
Q4 | $969M | Buy |
|
|||||
|
2024
Q3 | $977M | Sell |
|
|||||
|
2024
Q2 | $1.15B | Sell |
|
|||||
|
2024
Q1 | $1.22B | Sell |
|
|||||
|
2023
Q4 | $1.35B | Sell |
|
|||||
|
2023
Q3 | $1.25B | Sell |
|
|||||
|
2023
Q2 | $1.24B | Sell |
|
|||||
|
2023
Q1 | $1.39B | Sell |
|
|||||
|
2022
Q4 | $1.49B | Sell |
|
|||||
|
2022
Q3 | $1.25B | Sell |
|
|||||
|
2022
Q2 | $1.24B | Sell |
|
|||||
|
2022
Q1 | $1.16B | Buy |
|
|||||
|
2021
Q4 | $1.31B | Buy |
|
|||||
|
2021
Q3 | $1.15B | Buy |
|
|||||
|
2021
Q2 | $1.18B | Buy |
|
|||||
|
2021
Q1 | $895M | Buy |
|
|||||
|
2020
Q4 | $859M | Buy |
|
|||||
|
2020
Q3 | $587M | Buy |
|
|||||
|
2020
Q2 | $446M | Sell |
|
|||||
|
2020
Q1 | $333M | Sell |
|
|||||
|
2019
Q4 | $371M | Buy |
|